Diagnosis and treatment of community-acquired pneumonia in adults. Recommendations for clinical practice;Diagnostic et traitement de la pneumonie acquise a domicile de l'adulte. Recommandations pour la pratique clinique

Revue Medicale de la Suisse Romande

Volumn 119, Issue 5, 1999, Pages 403-427

  Lamy, O ^a,j   Zanetti, G ^b   Bille, J ^c   Aubert, J D ^d   Cornuz, J ^e   Burnand, B ^f   Berger, J P ^g   Malinverni, R ^h   Rochat, Th ⁱ  

^a Médecine Interne A ^*  (France)

^b Division des Maladies Infectieuses

^c Institut de Microbiologie   (Switzerland)

^d Division de Pneumologie

^e Div d'Eval et de Coord des Soins

^f Ctr d'Epidemiol Clinique   (Switzerland)

^g Hopital Riviera   (Switzerland)

^h UNIVERSITY OF BERN   (Switzerland)

ⁱ GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^j LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPENICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; FLUCLOXACILLIN;

ANTIBIOTIC THERAPY; BREATHING EXERCISE; MORBIDITY; MORTALITY; OXYGEN SATURATION; OXYGEN THERAPY; PNEUMONIA; PROGNOSIS; REVIEW; SYMPTOMATOLOGY; THORAX RADIOGRAPHY; TREATMENT OUTCOME; VACCINATION;

EID: 6544294757     PISSN: 00353655     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (122)

1. Barlett J.G., Mundy L.M.: Community-acquired pneumonia. N. Engl. J. Med., 333: 1618-1624 (V), 1995.
2. Marrie T.J.: Community-acquired pneumonia. Clinical Inf. Dis., 18: 501-515 (V), 1994. Macfarlane J.T., Colville A., Guion A., Macfarlane R.M., Rose D.H.: Prospective study of etiology and outcome of adult lower-respiratory-tract infections in the community. Lancet, 341: 511-514 (V), 1993.
3. Marrie T.J.: Community-acquired pneumonia. Clinical Inf. Dis., 18: 501-515 (V), 1994. Macfarlane J.T., Colville A., Guion A., Macfarlane R.M., Rose D.H.: Prospective study of etiology and outcome of adult lower-respiratory-tract infections in the community. Lancet, 341: 511-514 (V), 1993.
4. Fox R.A.: Treatment recommendations for respiratory tract infections associated with aging. Drug & Aging, 3: 40-48 (V), 1993.
5. Guest J.F., Morris A.: Community-acquired pneumonia: the annual cost to the national health service in the UK. Eur. Respir. J., 10: 1530-1534 (V), 1997.
6. Fire M.J., Smith M.A., Carson C.A., Mutha S.S., Sankey S.S. et al.: Prognosis and outcome of patients with community-acquired pneumonia. A meta-analysis. JAMA, 275: 134-141 (III), 1996.
7. Rello J., Rodriguez R., Jubert P., Alvarez B.: Severe community-acquired pneumonia in the elderly: epidemiology and prognosis. Clinical Inf. Dis., 23: 72 3-728 (V), 1996.
8. Hedlund J.U., Ortquist A.B., Kalin M.E., Granath F.: Factors of importance for the long term prognosis after hospital treated pneumonia. Thorax, 48: 785-789 (III), 1993.
9. American Thoracic Society: Guidelines for the initial mangement of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am. Rev. Respir. Dis., 148: 1418-1426 (V), 1993.
10. Guidelines for the management of community-acquired pneumonia in adults admitted to hospital. British J. Hosp. Med., 49: 346-350 (V), 1993.
11. SPILF, Société de Pathologie Infectieuse de Langue Française: Infections des voies respiratoires: conférence de consensus en thérapeutique anti-infectieuse. Rev. Med. Infect., 21: S1-S8 (V), 1991.
12. Dorca J., Bello S., Blanquer J., De Celis R., Molinos L., Torres A. et al.: The diagnosis and treatment of community-acquired pneumonia. SEPAR. Arch. Broncopneumol., 33: 240-246 (V), 1997.
13. Mandell L.A., Niederman M.: The canadian community-acquired pneumonia consensus conference group. Can. J. Infect. Dis., 4: 25-28 (V), 1993.
14. Galdroni Grassi G., Bianchi L.: Guidelines for the management of community-acquired pneumonia in adults. Monaldi Arch. Dis. Chest., 50: 21-27 (V), 1995.
15. Guidelines for management of adult community-acquired lower respiratory tract infections. ERS Task force report. Eur. Respir. J., 11: 986-991 (V), 1998.
16. ESOCAP committee: Management of adult community-acquired lower respiratory tract infections. Eur. Respir. J., 11: 61, 391-426 (V), 1998.
17. Bartlett J.G., Breimann R.F., Mandell L.A., File T.M.: Guidelines from the infectious diseases society of America. Community-acquired pneumonia in adults: guidelines for management. Clin. Infect. Dis., 26: 811-838 (V), 1998.
18. Niederman M.S.: Community-acquired pneumonia: A north american perspective. Chest, 113: 179S-182S (V), 1998.
19. Woodhead M.: Community-acquired pneumonia guidelines - an international comparison. Chest, 183S-187S (V), 1998.
20. Gleason P.P., Kapoor M.D., Stone R.A., Lave J.R., Obrovsky D.S., Schultz R. et al.: Medical outcomes and antimicrobial costs with the use of the american thoracic society guidelines for outpatients with community-acquired pneumonia. JAMA, 278: 32-39 (III), 1997.
21. Fein A.M., Niederman M.S.: Guidelines for the initial management of community-acquired pneumonia: savory recipe or cookbook for disaster? Am. J. Respir. Crit. Care Med., 152: 1149-1153 (V), 1995.
22. Huchon G., Gialdroni-Grassi G., Leophonte P., Manresa F., Schaberg T., Woodhead M.: Initial antibiotic therapy for lower respiratory tract infection in the community: a european survey. Eur. Resp. J., 9: 1590-1595 (IV), 1996.
23. Woodhead H., Gialdroni Grassi G., Huchon G.J., Leophonte P., Manresa F., Schaberg T.: Use of investigations lower respiratory tract infection in the community: a European survey. Eur. Respir. J., 9: 1596-1600 (IV), 1996.
24. Jankneght R., Wijnands W.J.A., Stobberingh E.E.: Antibiotic policies in dutch hospitals for the treatment of pneumonia. Journal of Antimicrobial Chemotherapy, 34: 431-442 (V), 1994.
25. Fine M.J., Singer D.E., Phelps A.L., Hanusa B.H., Kapoor W.N.: Differences in length of hospital stay in patients with community-acquired pneumonia: a prospective four-hospital study. Medical Care, 31: 371-380, 1993.
26. Fine M.J., Hough L.J., Medsger A.R., Li Y.H., Singer D.E. et al.: The hospital admission decision for patients with community-acquired pneumonia. Arch. Intern. Med., 157: 36-44 (III), 1997.
27. Fine M.J., Medsger A.R., Stone R.A., Marrie T.J., Coley C.M., Singer D.E. et al.: The hospital discharge decision for patients with community-acquired pneumonia. Arch. Intern. Med., 157: 47-56 (III), 1997.
28. Weingarten S.R., Riedinger M.S., Varis G., Noah M.S., Belman M.J., Meyer R.D. et al.: Identification of low-risk hospitalized patients with pneumonia. Chest, 105: 1109-1115 (IV), 1994.
29. Fine M.J., Smith D.N., Singer D.E.: Hospitalisation decision in patients with community-acquired pneumonia: a prospective cohort study. Am. J. Med., 89: 713-721 (V), 1990.
30. Taytard A., Touron D., Lorioux D., Masson F., Vernejoux J.M., Tunon de Lara J.M.: Stratégies diagnostiques et thérapeutiques devant les pneumopathies aiguës en pratique de ville. Rev. Mal. Resp., 11: 385-391 (V), 1994.
31. Houston M.S., Silverstein M.D., Suman V.J.: Risk factors for 30-day mortality in elderly patients with lower respiratory tract infection. Arch. Intern. Med., 157: 2190-2195 (IV), 1997.
32. Howarth-Frey CI., Stalder H.: Pneumonies. Guidelines de la policlinique de médecine. Méd. et Hyg., 54: 1733-1737 (V), 1996.
33. Metlay J.P., Schulz R., Li Y.H., Singer D.S., Marrie T.J., Coley C.M. et al.: Influence of age on symptomes at presentation in patients with community-acquired pneumonia. Arch. Intern. Med., 157: 1453-1459 (III), 1997.
34. Marrie T.J., Durant H., Yates L.: Community-acquired pneumonia requiring hospitalisation: 5-year prospective study. Review of infectious diseases, 11: 586-599 (V), 1989.
35. Fang G.D., Fine M., Orloff J., Arisumi D., Yu V.L., Kapoor W. et al.: New and emerging etiologies for community-acquired pneumonia with implications for therapy. Medicine (Baltimore), 69: 307-316 (V), 1990.
36. Farr B.M., Kaiser D.L., Harrison B.D.W., Connolly C.K.: Prediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical features. Thorax, 44: 1031-1035 (III), 1989.
37. Fein A.M.: Pneumonia in the elderly. Medical Clinics of north america, 78: 1015-1018 (V), 1994.
38. Marrie T.J., Peeling R.W., Fine M.J., Singer D.E., Coley C.M., Kapoor W.N.: Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course. Am. J. Med., 101: 508-515 (III), 1996.
39. Darowski A., Najim Z., Weinberg J., Guz A.: Hypothermia and infection in elderly patients admitted to hospital. Age ageing, 20: 193-198 (IV), 1991.
40. Metlay J.P., Kapoor W.N., Fine J.M.: Does this patient have community-acquired pneumonia? JAMA, 278: 1440-1445 (I), 1997.
41. Metlay J.P., Stafford R.S., Singer D.E.: National trends in the management of acute cought by primary care physicians. J. Gen. Intern. Med., 12 (suppl.): 77, 1997.
42. Heckerling P.S.: The need for chest roentgenograms in adults with acute respiratory illness: clinical predictors. Arch. Intern. Med., 146: 1321-1324 (IV), 1986.
43. Diehr P., Wood R.W., Bushyhead J., Krueger L., Wolcott B., Tompkins R.K.: Prediction of pneumonia in outpatients with acute cought: a statistical approach. J. Chron. Dis., 37: 215-225 (III), 1984.
44. Singal B.M., Hedges J.R., Radack KI.: Decisions rules and clinical of pneumonia: evaluation of low-yield criteria. Ann. Emerg. Med., 18: 13-20 (III), 1989.
45. Heckerling P.S., Tape T.G., Wiglon R.S.: Clinical prediction rule for pulmonary infiltrates. Ann. Intern. Med., 113: 664-670 (III), 1990.
46. Gennis P., Gallacher J., Falvo C., Baker S., Than W.: Clinical criteria for the detection of pneumonia in adults: guidelines for ordering chest roentgenograms in the emergency department. J. Emerg. Med., 7: 263-268 (III), 1989.
47. Emmermann C.L., Dawson N., Speroff T.: Comparison of physician judgement and decision aids for ordering chest radiographs for pneumonia in outpatients. Ann. Emerg. Med., 20: 1215-1219 (III), 1991.
48. Glossary of terms for thoracic radiology: recommendations of the nomenclature committee of the Fleischner society. AJR, 143: 509-517 (V), 1984.
49. Hasley P.B., Albaum M.N., Li Y.H., Fuhrman C.R., Britton C.A., Marrie T.J. et al.: Do pulmonary radiographic findings at presentation predict mortality in patients with community-acquired pneumonia. Arch. Int. Med., 156: 2206-2212 (III), 1996.
50. Franken E.A., Bergus G.R., Koch T.J., Berbaum K.S., Smith W.L.: Added value of radiologist consultation to family practitioners in the outpatient setting. Radiology, 197: 759-762 (III), 1995.
51. Conférence de consensus: Les infections des voies respiratoires. Rev. Mal. Resp., 9: 477-480 (V), 1992.
52. Opravil M., Marincek B., Fuchs W.A. et al.: Shortcomings of chest radiography in detecting Pneumocystis carinii pneumonia. J. Acquir. Immune Defic. Syndr., 7: 39-45 (III), 1994.
53. Fine M.J., Auble T.E., Yealy D.M., Hanusa B.H., Weissfeld L.A., Singer D.E. et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N. Engl. J. Med., 336: 243-250 (IV), 1997.
54. Finch R.G., Woodhead M.A.: Practical considerations and guidelines for the management of community-acquired pneumonia. Drugs, 55: 31-45 (V), 1998.
55. Macfarlane J.T., Miller A.C., Roderick Smith W.H., Morris A.H., Rose D.H.: Comparative radiographic features of community-acquired legionnaires' disease, pneumococcal pneumonia, mycoplasma pneumonia, and psittacosis. Thorax, 39: 28-33 (IV), 1984.
56. Donowitz G.R., Harman C., Pope T., Stewart F.M.: The role of the chest roentgenogram in febrile neutropenic patients. Arch. Intern. Med., 151: 701-704 (IV), 1991.
57. Yu V.L., Kroboth F.J., Brown A:, McDearman S., Magnussen M.: Legionnaires' disease: new clinical perspective from a prospective pneumonia study. Am. J. Med., 73: 357-361 (III), 1982.
58. Stout J.E., Yu V.L.: Legionellosis. N. Eng. J. Med., 337: 682-687 (V), 1997.
59. Smith R.P., Lipworth B.J.: C-reactive proteine in simple community-acquired pneumonia. Chest, 107: 1028-1321 (IV), 1995.
60. Meyer R.J., Town G.I., Harré E., Koning M., Hurrel M., Beard M.E.J.: An audit of the assessement and management of adults admitted to Christchurch hospital with community-acquired pneumonia. NZ Med. J., 110: 349-352 (III), 1997.
61. Nicod L.P.: Epanchements parapneumoniques. Evaluation et traitement. Méd. et Hyg., 55: 2312-2315 (V), 1997.
62. Moine P., Vercken J.B., Chevret S., Chastang C., Gajdos R.: Severe community-acquired pneumonia. Etiology, epidemiology, and prognosis factors. Chest, 105: 1487-1495 (V); 1994.
63. British Thoracic Society Research Committee: Community-acquired pneumonia in adults in british hospitals in 1982-1983: a survey of aetiology, mortality, prognostic factors and outcomes. Quartely Journal of Medecine, 62: 195-220(V), 1987.
64. Fine M.J., Singer D.E., Hanusa B.H., Lave J.R., Kapoor W.N.: Validation of a pneumonia prognostic index using the medisgroups comparative hospital database. Am.J. Med., 94: 153-158 (IV), 1993.
65. Bates J.H., Campbel G.D., Barron A.L., McCracken G.A., Morgan P.N., Moses E.B., Davis C.M.: Microbial etiology of acute pneumonia in hospitalized patients. Chest, 101: 1005-1012 (III), 1992.
66. Zanetti G.: Pneumonies acquises à domicile: considérations sur la prise en charge ambulatoire. Schweiz. Med. Wochenschr., 127: 528-534 (V), 1997.
67. Reimer L.G., Caroll K.C.: Role of the microbiology laboratory in the diagnosis of lower respiratory tract infections. Clinical Infectious Diseases, 26: 742-748 (V), 1998.
68. Fishman JA, Roth R.S., Zanzot E., Eros E.J., Ferraro M.J.: Use of induced sputum specimens tor microbiologic diagnosis of infections due to organism other than Pneumocystis carinii. Journal of Clinical Microbiology, 32: 131-133 (III), 1994.
69. Ortquist A., Hedlund J., Grillner L., Jalonen E., Kallings I., Leinonen M. et al.: Aetiology, outcome and prognostic factors in community-acquired pneumonia requiring hospitalization. Eur. Resp. J., 3: 1105-1113 (V), 1990.
70. Schwartz D.N., Furumoto-Dawson A., Itokazu G.S., Chinikamwala M., Levasseur F., Weinstein R.A.: Preventing mismanagement of community-acquired pneumonia at an urban public hospital. Chest, 113: 194S-198S (IV), 1998.
71. Meehan T.P., Fine M.J., Krumholz H.M., Scinto J.D., Galusha D.H., Mockalis J.T. et al.: Quality of care, process, and outcomes in elderly with pneumonia. JAMA, 278: 2080-2084 (IV), 1997.
72. Tumbarello M., Tacconelli E., de Gaetano K., Ardito F., Pirronti T., Cauda R. et al.: Bacterial pneumonia in HIV-infected patients: analysis of risk factors and prognostic indicators. J. Acq. Immun. Def. Syn. Hum. Retrovirology, 18: 39-45 (IV), 1998.
73. Ortquist A., Kalin M., Lejdeborn L., Lundberg B.: Diagnostic fiberoptic bronchoscopy and protected brush culture in patients with community-acquired pneumonia. Chest, 97: 576-582 (III), 1990.
74. Atlas S.J., Benzer T.J., Borowsky L.H., Chang Y.C., Burnham D.C., Metlay J.P. et al.: Safety increasing the proportion of patients with community-acquired pneumonia treated as outpatients. Arch. Intern. Med., 158: 1350-1356 (III), 1998.
75. Black E.R., Mushlin A.I., Griner P.F., Suchman A.L., James R.K., Schoch D.R.: Predicting the need for hospitalization of ambulatory patients with pneumonia. J. Gen. Intern. Med., 6: 394-400 (IV), 1991.
76. Farr B.M., Sloman A.J., Fisch M.J.: Predicting death in patients hospitalized for community-acquired pneumonia. Annals of Internal Medicine, 115: 428-436 (IV), 1991.
77. Neill A.M., Martin I.R., Weir R., Anderson R., Chereshsky A., Epton M.J. et al.: Community-acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax, 51: 1010-1016 (IV), 1996.
78. Pachon J., Pados M.D., Capote F., Cuello J.A., Garnacho J., Verano A.: Severe community-acquired pneumonia. Am. Rev. Respir. Dis., 142: 369-373 (V), 1990.
79. Hedlund J., Hansson L.O., Ortqvist A.: Short and long-term prognosis for middle-aged and eldery patients hospitalized with community-acquired pneumonia: impact of nutritional and inflammatory factors. Scand. J. Infect. Dis., 27: 32-37 (III), 1995.
80. Fernandez-Sola J., Junque A., Estruch R., Monforte R., Torres A., Urbano-Marquez A.: High alcohol intake as a risk and prognostic factor for community-acquired pneumonia. Arch Intern. Med., 155: 1649-1654 (IV), 1995.
81. Saitz R., Ghali W.A., Moskowitz M.A.: The impact of alcohol-related diagnoses of pneumonia outcomes. Arch. Intern. Med., 157: 1446-1452 (V), 1997.
82. Schaberg T., Gialdroni-Grassi G., Huchon G., Leophonte P., Manresa F., Woodhead M.: An analysis of decisions by european general practitionners to admit to hospital patients with lower respiratory tract infections. Thorax, 51: 1017-1022 (IV), 1996.
83. Coley C.M., Li Y.H., Medsger A.R., Marrie T.J., Fine M.J., Kapoor W.N. et al.: Preferences for home vs hospital care among low-risk patients with community-acquired pneumonia. Arch. Intern. Med., 1565-1571 (V), 1996.
84. Ortqvist A.: Antibiotic treatment of community-acquired penumonia in clinical practice: a European perspective. Journal of Antimicrobial Chemotheray, 35: 205-212 (V), 1995.
85. Kenneth G., Gleason P.P., Singer D.E., Marrie T.J., Coley C.M., Obrosky S. et al.: Variations in antimicrobial use and cost in more than 2000 patients with community-acquired pneumonia. Am. J. Med., 104: 17-27 (III), 1998.
86. Young L.S.: Editorial response: a new fluoroquinolone for community-acquired pneumonia. Clin. Infectious Dis., 26: 1322-1323 (V), 1998.
87. Vogel F.: Sequential therapy in the hospital management of lower respiratory infections. Am. J. Medicine, 99 (S6B): 13-18 (V), 1995.
88. Ramirez J.A., Srinath L., Ahkee S., Huang A., Raff M.J.: Early switch from intravenous to oral cephalosporins in the treatment of hospitalized patients with community-acquired pneumonia. Arch. Intern. Med., 155: 1273-1276 (III), 1995.
89. Cassiere H.A., Fein A.M.: Duration and route of antibiotic therapy in community pneumonia: switch and step-down therapy. Seminars in respiratory infections, 13: 36-42 (V), 1998.
90. Halm E.A., Fine M.J., Marrie T.J., Coley C.M., Kapoor W.N., Obrosky S. et al.: Time to clinical stability in patients hospitalized with community-acquired pneumonia. Implications for practice guidelines. JAMA, 279: 1452-1457 (III), 1998.
91. Weingarten S.R., Riedinger M.S., Hobson P., Noah M.S., Johnson B., Giugliano G. et al.: Evaluation of a pneumonia practice guideline in an interventional trial. Am. J. Respir. Crit. Care Med., 153: 1110-1115 (III), 1996.
92. Brambilla C., Kastanakis, Knight S., Cunningham K.: Cefuroxime and cefuroxime axetil versus Amoxicillin plus Clavunic acid in the treatment of lower respiratory tract infections. Eur. J. Clin. Microbiol. Infect. Dis., 11: 118-124 (I), 1992.
93. Nathwani D.: Sequential switch therapy for lower respiratory tract infections. Chest, 113: 211S-218S (V), 1998.
94. Rhew D.C., Hackner D., Henderson L., Ellrodt A.G., Weingarten S.R.: The clinical benefit of in-hospital observation in «low risk» pneumonia patients after conversion from parenteral to oral antimicrobial therapy. Chest, 113: 142-146 (IV), 1998.
95. Siegel E.R., Alicea M., Lee A., Blaiclock R.: Community-acquired pneumonia: determination of the optimal duration of therapy. Chest, 112: 5S-6S, 1997.
96. Alkhayer M., Jenkins P.F., Harrison B.D.W.: The outcome of community-acquired pneumonia treated on the intensive care unit. Respiratory Medicine, 84: 13-16 (V), 1990.
97. Sutton P.P., Pavia D., Bateman J.R.M., Clarke S.W.: Chest physiotherapy: a review. Eur. J. Respir. Dis., 63: 188-201 (V), 1982.
98. LaForce F.M.: Community-acquired lower respiratory tract infections. Prevention and cost-control strategies. Am. J. Med., 78: 52-57 (V), 1985.
99. Graham W., Bradley D.: Efficacity of chest physiotherapy and intermittent positive pressure breathing in the resolution of pneumonia. N. Engl. J. Med., 299: 624-627 (I), 1978.
100. Britton B., Bejstedt M., Vedin L.: Chest physiotherapy in primary pneumonia. B.M.J., 290: 1703-1704 (I), 1985.
101. Bjorkvist M., Wiberg B., Bodin L., Barany M., Holmberg H.: Bottle-blowing in hospital-treated patients with community-acquired pneumonia. Scand. J. Infect. Dis., 77-82 (II), 1997.
102. Stapleton T.: Chest physiotherapy in primary pneumonia. B.M.J., 291: 143 (V), 1985.
103. Riquelme R., Torres A., El-Ebiary M., Mensa J., Estruch R., Ruiz M.: Community-acquired pneumonia in the elderly. Clinical and nutritional aspects. Am. J. Respir. Crit. Care Med. Med., 156: 1908-1914 (III), 1997.
104. Woo J., Ho S.C., Mak Y.T., Law L.K., Cheung A.: Nutritional status of elderly patients during recovery from chest infection and the rôle of nutritional supplementation assessed by a prospective randomized single-blind trial. Age and Aging, 23: 40-48 (I), 1994.
105. Hansson L.O., Hedlung J.U., Ortqvist A.B.: Sequential changes of inflammatory and nutritional markers in patients with community-acquired pneumonia. Scand. J. Lab. Invest., 57: 111-118 (III), 1997.
106. Mittl R.J., Schwab R.J., Duchin J.S., Coin J.E., Albeida S.M., Miller W.T.: Radiographic resolution of community-acquired pneumonia. Am. J. Respir. Crit. Care Med., 149: 630-635 (III), 1994.
107. Jay S.J., Johanson W.G., Pierce A.K.: The radiographic resolution of Streptococcus pneumoniae pneumonia. N. Engl. J. Med., 293: 798-801 (III), 1975.
108. Feinsilver S.H., Fein A.M., Niederman M.S., Schultz D.E., Faegenburg D.H.: Utility of fiberoptic bronchoscopy in non resolving pneumonia. Chest, 98: 1322-1326 (V), 1990.
109. Rohweder J.J.: Enticements for fruitless bronchoscopy. Chest, 96: 708-710 (V), 1989.
110. Hedlung J., Kalin M., Ortqvist A.: Recurrence of pneumonia in middle-aged and elderly adults after hospital-treated pneumonia: aetiology and predisposing conditions. Scand. J. Infect. Dis., 29: 387-392 (III), 1997.
111. Brancati F.L., Chow J.W., Wagener M.M., Vacarello S.J., Yu V.L.: Is pneumonia really the old man's friend? Two-year prognosis after community-acquired pneumonia. Lancet, 342: 30-33 (III), 1993.
112. Minogue M.F., Coley C.M., Fine M.J., Marrie T.J., Kapoor W.N., Singer D.E. Patients hospitalized after initial outpatient treatment for community-acquired pneumonia. Ann. Emerg. Med., 31: 376-380 (IV), 1998.
113. Metlay J.P., Fine M.J., Schultz R., Marrie T.J., Coley C.M., Kapoor W.N., Singer D.E.: Measuring symptomatic and functional recovery in patients with community-acquired pneumonia. J. Gen. Intern. Med., 12: 423-430 (III), 1997.
114. Covaert T.M., Thijs C.T., Masurel N. et al.: The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled study. Journal of the American Medical Association, 272: 1661-1665 (I), 1994.
115. C. Büla, P. Francioli: Vaccinations. In: «Infections in the elderly», C. Büla, K. Kauffmann Eds Baillière's Clinical Infectious Disease, 5: 17-34 (V), 1998.
116. Nichol K.L., Margolis K.L., Wuorenma J., Von Sternberg T.: The efficacy and cost effectiveness of vaccination agaist influenzae among elderly persons living in the community. N. Engl. J. Med., 331: 778-784 (IV), 1994.
117. Puig-Barbera J., Marquez-Calderon S., Masoliver-Fores A., Lloria-Paes F., Ortega-Dicha A., Gil-Martin M. et al.: Reduction in hospital admissions for pneumonia in non-institutional elderly people as a result of influenza vaccination: a cas-control study in Spain. J. Epidemiol. Community Health, 51: 526-530 (IV), 1997.
118. Gross P.A., Hermogenes A.W., Sacks H.S., Lau J., Levandowski R.A.: The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann. Intern. Med., 123: 518-527 (IV), 1995.
119. Nichol K.L., Wuorenma J., von Sternberg T.: Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Arch. Intern. Med., 158: 1769-1776 (IV), 1998.
120. Buther J.C., Breiman R.F., Campbell J.F., Lipman H.B., Broome C.V., Facklam R.R.: Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommandations. JAMA, 270: 1826-1831 (IV), 1993.
121. Fedson D.S., Shapiro E.D., LaForce F.M., Mufson M.A., Musher D.M., Spika J.S.: Pneumococcal vaccine after 15 years of use. Arch. Intern. Med., 154: 2531-2535 (V), 1994.
122. Shapiro E.D., Berg A.T., Austrian R., Schroeder D., Parcells V., Margolis A.: The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N. Engl. J. Med., 325: 1453-1460 (IV), 1991.